---
$id: https://graph.org.ai/products/commodity/51201821
$type: Product
source: UNSPSC
code: "51201821"
title: "Tiprotimod"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tiprotimod

**UNSPSC Code**: 51201821
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunostimulant with the molecular formula C10H13NO4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FZ7ZH245CO, chemically known as 5-thiazoleacetic acid, 2-((3-carboxypropyl)thio)-4-methyl- but generally known as tiprotimod, which bears US NIH Compound Identifier 65890. European Medicines Agency schedules Tiprotimod in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11110MIG. The term TIPROTIMOD is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). TIPROTIMOD is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tiprotimod under HS 29341000 and SITC 51579. As of Q4 2014, TIPROTIMOD remains the US FDA Preferred Term for this commodity. Tiprotimod bears US NLM identifiers UMLS ID C0076719 and NCI Concept Code C76689. SMILES: CC1=C(SC(=N1)SCCCC(=O)O)CC(=O)O.

